BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17942404)

  • 1. Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17.
    Ali N; Knaüper V
    J Biol Chem; 2007 Dec; 282(52):37378-88. PubMed ID: 17942404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer.
    Gaweł-Bęben K; Ali N; Ellis V; Velasco G; Poghosyan Z; Ager A; Knäuper V
    Cell Biol Int; 2018 Mar; 42(3):273-280. PubMed ID: 28762604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).
    Lambert DW; Yarski M; Warner FJ; Thornhill P; Parkin ET; Smith AI; Hooper NM; Turner AJ
    J Biol Chem; 2005 Aug; 280(34):30113-9. PubMed ID: 15983030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer.
    Afar DE; Bhaskar V; Ibsen E; Breinberg D; Henshall SM; Kench JG; Drobnjak M; Powers R; Wong M; Evangelista F; O'Hara C; Powers D; DuBridge RB; Caras I; Winter R; Anderson T; Solvason N; Stricker PD; Cordon-Cardo C; Scher HI; Grygiel JJ; Sutherland RL; Murray R; Ramakrishnan V; Law DA
    Mol Cancer Ther; 2004 Aug; 3(8):921-32. PubMed ID: 15299075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor suppressor activity of the transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) correlates with its ability to modulate sarcosine levels.
    Chen X; Overcash R; Green T; Hoffman D; Asch AS; Ruiz-Echevarría MJ
    J Biol Chem; 2011 May; 286(18):16091-100. PubMed ID: 21393249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectodomain shedding of the Notch ligand Jagged1 is mediated by ADAM17, but is not a lipid-raft-associated event.
    Parr-Sturgess CA; Rushton DJ; Parkin ET
    Biochem J; 2010 Dec; 432(2):283-94. PubMed ID: 20819075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17.
    Schwarz J; Broder C; Helmstetter A; Schmidt S; Yan I; Müller M; Schmidt-Arras D; Becker-Pauly C; Koch-Nolte F; Mittrücker HW; Rabe B; Rose-John S; Chalaris A
    Biochim Biophys Acta; 2013 Dec; 1833(12):3355-3367. PubMed ID: 24135057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules.
    Ludwig A; Hundhausen C; Lambert MH; Broadway N; Andrews RC; Bickett DM; Leesnitzer MA; Becherer JD
    Comb Chem High Throughput Screen; 2005 Mar; 8(2):161-71. PubMed ID: 15777180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPP1 Ectodomain Shedding is Mediated by ADAM17 and is Necessary for Tumor Suppression in Colon Cancer.
    Elahi A; Ajidahun A; Hendrick L; Getun I; Humphries LA; Hernandez J; Shibata D
    J Surg Res; 2020 Oct; 254():183-190. PubMed ID: 32450419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytosolic domain of protein-tyrosine kinase 7 (PTK7), generated from sequential cleavage by a disintegrin and metalloprotease 17 (ADAM17) and γ-secretase, enhances cell proliferation and migration in colon cancer cells.
    Na HW; Shin WS; Ludwig A; Lee ST
    J Biol Chem; 2012 Jul; 287(30):25001-9. PubMed ID: 22665490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen signaling promotes translation of TMEFF2 in prostate cancer cells via phosphorylation of the α subunit of the translation initiation factor 2.
    Overcash RF; Chappell VA; Green T; Geyer CB; Asch AS; Ruiz-Echevarría MJ
    PLoS One; 2013; 8(2):e55257. PubMed ID: 23405127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells.
    Chen X; Corbin JM; Tipton GJ; Yang LV; Asch AS; Ruiz-Echevarría MJ
    Biochim Biophys Acta; 2014 Jun; 1843(6):1216-24. PubMed ID: 24632071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin A2 regulates a disintegrin and metalloproteinase 17-mediated ectodomain shedding of pro-tumor necrosis factor-α in monocytes and colon epithelial cells.
    Tsukamoto H; Tanida S; Ozeki K; Ebi M; Mizoshita T; Shimura T; Mori Y; Kataoka H; Kamiya T; Fukuda S; Higashiyama S; Joh T
    Inflamm Bowel Dis; 2013 Jun; 19(7):1365-73. PubMed ID: 23702712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMEFF2 modulates the AKT and ERK signaling pathways.
    Chen X; Ruiz-Echevarría MJ
    Int J Biochem Mol Biol; 2013; 4(2):83-94. PubMed ID: 23936739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.
    Green T; Chen X; Ryan S; Asch AS; Ruiz-Echevarría MJ
    Prostate; 2013 Oct; 73(14):1561-75. PubMed ID: 23824605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
    Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
    J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
    Guo S; Peng M; Zhao Q; Zhang W
    Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme.
    Nishi E; Hiraoka Y; Yoshida K; Okawa K; Kita T
    J Biol Chem; 2006 Oct; 281(41):31164-72. PubMed ID: 16923819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
    Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
    Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17.
    Sahin U; Blobel CP
    FEBS Lett; 2007 Jan; 581(1):41-4. PubMed ID: 17169360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.